We are live on ! Find out more
QTTB icon

Q32 Bio
QTTB

66 hedge funds and large institutions have $640M invested in Q32 Bio in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 13

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

26% more capital invested

Capital invested by funds: $509M → $640M (+$132M)

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

2% more funds holding

Funds holding: 65 → 66 (+1)

0.05% more ownership

Funds ownership: 3.37% → 3.42% (+0.05%)

Holders
66
Holders Change
+1
Holders Change %
+1.54%
% of All Funds
1.43%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
9
Increased
26
Reduced
13
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$3.87M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.74M
3
RI
RTW Investments
New York
+$2.56M
4
MWNA
Marshall Wace North America
New York
+$2.31M
5
BB
BB Biotech
Switzerland
+$2.27M

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$6.16M
2
AG
Artal Group
Luxembourg
-$2.24M
3
RSCM
Rock Springs Capital Management
Maryland
-$1.99M
4
BlackRock
BlackRock
New York
-$1.46M
5
Invesco
Invesco
Georgia
-$900K
Name Holding Trade Value Shares
Change 		Change in
Stake
MLICM
51
Metropolitan Life Insurance Company (MetLife)
New York
$171K – – –
Citigroup
52
Citigroup
New York
$140K +$21.9K +49 +21%
Morgan Stanley
53
Morgan Stanley
New York
$124K -$555K -1,241 -83%
BNP Paribas Financial Markets
54
BNP Paribas Financial Markets
France
$99K +$88.5K +198 New
Legal & General Group
55
Legal & General Group
United Kingdom
$88K – – –
Marshall Wace
56
Marshall Wace
United Kingdom
$74K +$66.2K +148 New
Canada Life
57
Canada Life
Manitoba, Canada
$71K – – –
UBS Group
58
UBS Group
Switzerland
$42K +$9.39K +21 +34%
AIP
59
Ameritas Investment Partners
Nebraska
$39K +$13.9K +31 +65%
AG
60
Advisor Group
Arizona
$28K – – –
Royal Bank of Canada
61
Royal Bank of Canada
Ontario, Canada
$28K – – –
TRCT
62
Tower Research Capital (TRC)
New York
$14K +$12.1K +27 New
Daiwa Securities Group
63
Daiwa Securities Group
Japan
$7K -$2.68K -6 -32%
MAM
64
Meeder Asset Management
Ohio
$5K -$1.34K -3 -21%
Rockefeller Capital Management
65
Rockefeller Capital Management
New York
$5K +$4.47K +10 New
Federated Hermes
66
Federated Hermes
Pennsylvania
$3K – – –
AG
67
Artal Group
Luxembourg
– -$2.24M -5,556 Closed
Invesco
68
Invesco
Georgia
– -$900K -2,236 Closed
JGC
69
J. Goldman & Co
New York
– -$559K -1,389 Closed
OAM
70
Oxford Asset Management
United Kingdom
– -$552K -1,371 Closed
TM
71
Tiger Management
New York
– -$531K -1,319 Closed
EIM
72
Essex Investment Management
Massachusetts
– -$169K -421 Closed
PCM
73
Prelude Capital Management
New York
– -$93K -232 Closed
Bank of Montreal
74
Bank of Montreal
Ontario, Canada
– -$5K -13 Closed
1 2
3

QTTB Hedge Fund Activity: Q1 2019 in Review

66 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q1 2019, worth a combined $640M — up 26% from $509M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new QTTB positions and 8 closed out — a net gain of 1 holder — while 26 added to existing stakes and 13 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $3.87M. The largest seller was JP Morgan Chase, cutting an estimated $6.16M.

  • 66 institutional investors held Q32 Bio (QTTB) as of Q1 2019, up from 65 in Q4 2018.
  • Funds reported $640M of Q32 Bio stock for Q1 2019, up 26% quarter-over-quarter.
  • 9 funds opened new Q32 Bio positions in Q1 2019 and 8 closed out, a net change of +1 holder.
  • The largest Q32 Bio buyer in Q1 2019 was Lord, Abbett & Co, an estimated $3.87M added.
  • The largest Q32 Bio seller in Q1 2019 was JP Morgan Chase, an estimated $6.16M sold.

Based on aggregated 13F filings for Q1 2019.